Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head

British Journal of Dermatology

Volumn 157, Issue 1, 2007, Pages 133-141

  Alomar, A ^a   Bichel, J ^b   McRae, S ^c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b 3M Deutschland GmbH   (Germany)

^c 3M COMPANY   (United States)

Author keywords

Actinic keratoses; Imiquimod; Neoplasm; Senile keratoses

Indexed keywords

IMIQUIMOD; PLACEBO;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG WITHDRAWAL; DRY SKIN; EDEMA; EROSION; ERYTHEMA; EXUDATE; FEMALE; FOLLOW UP; HEAD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCAL SKIN REACTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; SCALP; SKIN BIOPSY; SKIN ULCER; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; AMINOQUINOLINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERFERON INDUCERS; KERATOSIS; MALE; MIDDLE AGED; OINTMENTS; PHOTOSENSITIVITY DISORDERS; SCALP DERMATOSES; SKIN NEOPLASMS; SUNLIGHT; TREATMENT OUTCOME;

EID: 34250674001     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07942.x     Document Type: Article

References (19)

1. Callen JP, Bickers DR, Moy RL. Actinic keratosis. J Am Acad Dermatol 1997 36 : 650 3.
2. Yantsos VA, Conrad N, Zabawski E et al. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg 1999 18 : 3 14.
3. Kocsard E. Solar keratoses and their relationship to non-melanoma skin cancers. Australas J Dermatol 1997 38 (Suppl. 1 S30.
4. Uhoda I, Quatresooz P, Pierard-Franchimont C, Pierard GE. Nudging epidermal field cancerogenesis by imiquimod. Dermatology 2003 206 : 357 60.
5. Carlson JA, Scott D, Wharton J et al. Incidental histopathologic pattern: possible evidence of field cancerisation surrounding skin tumors. Am J Dermpathol 2001 23 : 494 7.
6. Testerman TL, Gerster JF, Imbertson LM et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995 58 : 365 72.
7. Imbertson LM, Beaurline JM, Couture AM et al. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463. J Invest Dermatol 1998 110 : 734 9.
8. Lebwohl M, Dinehart S, Whiting D et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004 50 : 714 21.
9. Szeimies RM, Gerritsen MJ, Gupta G et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 2004 51 : 547 55.
10. Korman N, Moy R, Ling M et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol 2005 141 : 467 73.
11. Thai K-E, Fergin P, Freeman M et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol 2004 43 : 687 92.
12. Loven K, Stein L, Furst K, Levy S. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther 2002 24 : 990 1000.
13. Gupta AK, Davey V, McPhail H. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: critical review and meta-analysis of efficacy studies. J Cutan Med Surg 2005 9 : 209 14. Incorporating Medical and Surgical Dermatology [serial online]. 2 Mar 2006. Available from http://www.springerLink.com (accessed 3 April 2006).
14. Edwards L, Ferenczy A, Eron L et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998 134 : 25 30.
15. Reichard O, Gunnar N, Fryden A et al. Randomised, double-blind, placebo-controlled trial of interferon [alpha]-2b with and without ribavirin for chronic hepatitis C. Lancet 1998 351 : 83 7.
16. Duncan M, Berman B. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985 162 : 516 27.
17. Granstein RD, Flotte TJ, Amento EP. Interferons and collagen production. J Invest Dermatol 1990 95 (6 Suppl. 75S 80S.
18. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001 69 : 513 21.
19. Tucci M, Offidani A, Lucarini G et al. Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical study. J Eur Acad Dermatol Venereol 1998 10 : 118 24.